Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Executive Summary
The Global Cardiac Resynchronization Therapy (CRT) Devices Market was valued at USD 7.14 Billion in the year 2021 with the Americas region leading the regional market share. One of the main factors driving this market is the rising prevalence of cardiovascular diseases (CVDs) that lead to heart failure (HF). Each year, approximately 3.5 million people suffer from HF worldwide fostering the demand for cardiac resynchronization therapy devices. Additionally, factors such as technological advancements in devices, expanding CRT product developments, key company initiatives & investments, sedentary lifestyles and ageing demographics around the world are anticipated to impel the market growth in the forecast period.
The Asia Pacific CRT devices market is predicted to be the hotspot and the most lucrative region for the market participants worldwide. Some of the major factors propelling the growth of the cardiac resynchronization therapy devices market in the Asia Pacific region include a favourable reimbursement scenario in Japan, an ageing population in China, an increase in CVD incidence, an improved healthcare infrastructure, an expanding middle-class population, and rising disposable income levels in India.
The cardiac resynchronization therapy (CRT) devices market experienced a period of a temporary setback in the year 2020 as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19 virus. However, after the initial shock and confusion about COVID-19, companies and governments began taking corrective actions to help the economy and businesses recover. These measures included policy & monetary stimulus, easing of restrictions, conditional exemptions, and other strategic initiatives. This resulted in healthcare activities returning to normal pace towards the end of 2020 with the approval and administration of COVID-19 vaccines across the globe, thereby offering better growth prospects for the cardiac resynchronization therapy devices market during the forecast period.
Scope of the Report
• The report analyses the Cardiac Resynchronization Therapy Devices Market by Value (USD Billion).
• The report analyses the Cardiac Resynchronization Therapy Devices Market by Volume (in Million Units).
• The report analyses the Cardiac Resynchronization Therapy Devices Market by Product (CRT-Defibrillator and CRT-Pacemaker)
• The report analyses the Cardiac Resynchronization Therapy Devices Market by End User (Hospitals, Cardiac Centers and Research & Laboratories)
• The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Region (Americas, Europe, Asia Pacific, MEA).
• The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
• The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Product and by End User.
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
• The report tracks competitive developments, strategies, and Major Products & Developments and Mergers & Acquisitions. The companies analysed in the report include Medtronic, Boston Scientific Corp., Abbott Laboratories, Biotronik, MicroPort Scientific Corporation, Medico S.p.A, LivaNova and EBR Systems.
• The report presents the analysis of the Cardiac Resynchronization Therapy Devices Market for the historical period of 2017-2021 and the forecast period of 2022-2027.
Key Target Audience
• Cardiac Resynchronization Therapy Devices Manufacturers & Distributors
• End Users (Hospitals, Cardiac Centers, Research & Laboratories)
• Research and Development (R&D) Organizations
• Government Bodies & Regulating Authorities
• Investment Banks and Equity Firms
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Global Cardiac Resynchronization Therapy Devices Market: Product Overview
4. Global Cardiac Resynchronization Therapy Devices Market: An Analysis
4.1. Assessment of Macro Economic Indicators of Global Cardiac Resynchronization Therapy Devices Market
4.2 Global Cardiac Resynchronization Therapy Devices Market, Market Size, By Value, 2017-2027
4.3 Global Cardiac Resynchronization Therapy Devices Market, Market Size, By Volume, (Million Units), 2017-2027
4.4 Global Cardiac Resynchronization Therapy Devices Market: Growth and Forecast
4.5 Impact of COVID-19 on Global Cardiac Resynchronization Therapy Devices Market
5. Global Cardiac Resynchronization Therapy Devices Market: Segmental Analysis
5.1 Global Cardiac Resynchronization Therapy Devices Market Segmentation, By Product
5.2 Competitive Positioning of Cardiac Resynchronization Therapy Devices Market: By Product (2021 & 2027)
5.3 By CRT-Defibrillator, By Value (USD Billion), 2017-2027
5.4 By CRT-Pacemaker, By Value (USD Billion), 2017-2027
6. Global Cardiac Resynchronization Therapy Devices Market: Segment Analysis
6.1 Global Cardiac Resynchronization Therapy Devices Market Segmentation, By End-User
6.2 Competitive Positioning of Global Cardiac Resynchronization Therapy Devices Market, By End-User (2021 & 2027)
6.3 By Hospitals, By value (USD Billion), 2017-2027
6.4 By Cardiac Centers, By Value (USD Billion), 2017-2027
6.5 By Research & Laboratories, By Value (USD Billion), 2017-2027
7. Global Cardiac Resynchronization Therapy Devices Market: Regional Analysis
7.1 Competitive Positioning of Global Cardiac Resynchronization Therapy Devices Market: By Region (2021 & 2027)
8. Americas Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
8.1 Assessment of Macro Economic Indicators of Americas Cardiac Resynchronization Therapy Devices Market
8.2 Americas Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
8.3 Americas Cardiac Resynchronization Therapy Devices Market: Prominent Companies
8.4 Americas Cardiac Resynchronization Therapy Devices Market: Segment Analysis
8.5 Americas Cardiac Resynchronization Therapy Devices Market By Product (CRT-Defibrillator and CRT-Pacemaker)
8.6 Americas Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories)
8.7 Americas Cardiac Resynchronization Therapy Devices Market: Country Analysis
8.8 Market Opportunity Chart of Americas Cardiac Resynchronization Therapy Devices Market - By Country, By Value (Year-2027)
8.9 Competitive Positioning of Americas Cardiac Resynchronization Therapy Devices Market - By Country
8.10 United States Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
8.11 United States Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
8.12 Canada Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
8.13 Canada Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
9. Europe Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
9.1 Assessment of Macro Economic Indicators of Asia Pacific Cardiac Resynchronization Therapy Devices Market
9.2 Europe Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
9.3 Europe Cardiac Resynchronization Therapy Devices Market: Prominent Companies
9.4 Europe Cardiac Resynchronization Therapy Devices Market: Segment Analysis
9.5 Europe Cardiac Resynchronization Therapy Devices Market By Product (CRT-Defibrillator and CRT-Pacemaker), By Value, 2017-2027
9.6 Europe Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories), By Value, 2017-2027
9.7 Europe Cardiac Resynchronization Therapy Devices Market: Country Analysis
9.8 Market Opportunity Chart of Europe Cardiac Resynchronization Therapy Devices Market - By Country, By Value (Year-2027)
9.9 Competitive Positioning of Europe Cardiac Resynchronization Therapy Devices Market - By Country
9.10 Germany Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
9.11 Germany Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
9.12 United Kingdom Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
9.13 United Kingdom Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
9.14 France Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
9.15 France Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
9.16 Italy Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
9.17 Italy Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
9.18 Spain Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
9.19 Spain Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
10. Asia Pacific Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
10.1 Assessment of Macro Economic Indicators of Asia Pacific Cardiac Resynchronization Therapy Devices Market
10.2 Asia Pacific Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
10.3 Asia Pacific Cardiac Resynchronization Therapy Devices Market: Prominent Companies
10.4 Asia Pacific Cardiac Resynchronization Therapy Devices Market: Segment Analysis
10.5 Asia Pacific Cardiac Resynchronization Therapy Devices Market By Product, (CRT-Defibrillator and CRT-Pacemaker)
10.6 Asia Pacific Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories), By Value
10.7 Asia Pacific Cardiac Resynchronization Therapy Devices Market: Country Analysis
10.8 Market Opportunity Chart of Asia Pacific Cardiac Resynchronization Therapy Devices Market - By Country, By Value (Year-2027)
10.9 Competitive Positioning of Asia Pacific Cardiac Resynchronization Therapy Devices Market - By Country
10.10 China Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
10.11 China Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
10.12 Japan Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
10.13 Japan Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
10.14 India Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
10.15 India Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
11. MEA Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
11.1 Assessment of Macro Economic Indicators of MEA Cardiac Resynchronization Therapy Devices Market
11.2 MEA Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
11.3 MEA Cardiac Resynchronization Therapy Devices Market By Product, (CRT-Defibrillator and CRT-Pacemaker)
11.4 MEA Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories), By Value
12. Global Cardiac Resynchronization Therapy Devices Market Dynamics
12.1 Global Cardiac Resynchronization Therapy Devices Market Drivers
12.2 Global Cardiac Resynchronization Therapy Devices Market Restraints
12.3 Global Cardiac Resynchronization Therapy Devices Market Trends
13. Market Attractiveness and Strategic Analysis
13.1 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By Product (Year 2027)
13.2 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By End-User (Year 2027)
13.3 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By Region (Year 2027)
14. Competitive Landscape
14.1 Market Share of global leading companies
14.2 Recent Developments and Mergers & Acquisitions
14.3 Prominent Companies Worldwide Unit Sales of CRT Devices in FY 2021
15. Company Profiles (Business Description, Financial Analysis, Business Strategy)
15.1 Medtronic PLC
15.2 Boston Scientific
15.3 Abbott Laboratories
15.4 Biotronik
15.5 MicroPort Scientific Corporation
15.6 LivaNova PLC
15.7 Medico S.p.A
15.8 EBR Systems
Request Sample 
Request Discount 
Inquire Before Buy
